Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

NCT00383422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Arzoxifene
DRUG: Raloxifene

Sponsor

Eli Lilly and Company